Gen-Probe is among the worldwide leaders in the development, manufacture and marketing of nucleic acid tests. Its diagnostic solutions are used primarily to diagnose human diseases and screen donated blood. The company markets a portfolio of products that use proprietary technologies to detect infectious microorganisms that includes those that cause sexually transmitted diseases, tuberculosis, strep throat, pneumonia and fungal infections. Gen-Probe also manufactures one of the only Food and Drug Administration-approved blood-screening assays for the simultaneous detection of Human Immunodeficiency Virus-1 and Hepatitis C Virus. In addition, the company s TIGRIS instrument is one of the only fully automated, high throughput nucleic acid testing systems for diagnostics and blood screening. The company features more than 20 years of nucleic acid testing experience and its products are used daily in clinical laboratories and blood collection centers worldwide. Gen-Probe was established in 1985 and is based in San Diego.